Use of Metal Stents on Benign Esophageal Lesions

Withdrawn

• Conditions: Benign Esophageal Lesions
• Interventions: Procedure: Endoscopy

• Registration Number: NCT01238913
• Lead Sponsor: University of Florida

Brief Summary

The evaluation of using metal stents as medically indicated for the treatment of benign esophageal lesions.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-11-05
• Study First Submitted QC: 2010-11-09
• Study First Posted: 2010-11-11
• Status Verified: 2015-09
• Study Start: 2015-09
• Primary Completion: 2015-09
• Study Completion: 2015-09
• Last Update Submitted: 2015-09-29
• Last Update Posted: 2015-10-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Subject is 18 years or older
2. Subject has medical indication to undergo endoscopic placement of esophageal metal stent
3. Subject must be able to give informed consent

Exclusion Criteria

1. Any contraindications for endoscopic placement of esophageal metal stent
2. The subject is unable to give informed consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
benign esophageal lesions	Endoscopy	All patients who have a benign esophageal lesion where it is medically indicated that they receive a stent.

Primary Outcome Measures

Name	Time	Method
Successful stenting of Benign esophageal lesions	approximately 2-3 hours	This is an observational study to determine the effectiveness of stenting benign esophageal lesions with a metal stent.